-The Hindu The government must recognise the role low-cost health IT innovations could play in improving diagnostic accuracy, including many that would be useful for rural India The diagnosis of the first patient with Ebola in the U.S. was initially missed in an emergency room late night on September 25. Thomas Duncan, a Liberian national visiting Dallas, Texas, complained of flu-like symptoms and fever, but after lab work and CT scans, was...

-The Indian Express The tragedy of several women dying after undergoing sterilisation operations in the Bilaspur district of Chhattisgarh has once again thrown up uncomfortable questions around India's population programme. Although the cases are being investigated and the exact cause of the deaths has not been ascertained, the incident brings to light the abysmal conditions in which women are compelled to accept government-provided contraception. India is a signatory to an agreement at...

-Down to Earth Shortage of antiretroviral drugs and lack of diagnosis is not new in India, but government does not admit to the crisis The fight against HIV/AIDS in India is becoming tougher by the day as patients continue to face an acute shortage of antiretroviral drugs. This is an alarming situation for a country with the third-highest number of HIV+ people in the world-2.1 million. In 2012, about 140,000 people in...

-Economic and Political Weekly   This paper, based on NSS employment and unemployment data for various rounds since 1999-2000, highlights the trends and patterns of inclusion and exclusion in female employment across social groups. It provides evidence of increasing social inequalities in female employment, alongside worsening gender-based segregations. It also shows how specific attention to social and cultural variables could overturn standard assumptions regarding women's employment, which indeed has relevance for more...

-Business Standard Indian and other generic drug firms face prospect of US legislature debating compensation for undue price rises Indian generic drug makers might, if a proposed US law comes about, need to pay a rebate to the federal Medicaid programme there when prices of their medications outpace inflation. A Bill is to be introduced in the US Senate by a member, aimed to cushion the impact on taxpayers in this manner...